CONMED Corporation to Present at the BofA Securities Healthcare Conference
CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates [Yahoo! Finance]
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $115.00 to $75.00. They now have an "overweight" rating on the stock.
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Wells Fargo & Company from $98.00 to $77.00. They now have an "equal weight" rating on the stock.